TWSTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
Twist Bioscience Corp
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026
$139.77+7.02 (+5.29%)
Close on Oct 19, 2026
- Market cap
- $8.72B
- P/E (TTM)
- –
- Dividend yield
- –
Twist Bioscience Corp revenue by segment
By business segment
By product or service
| Revenue | Q3 26 | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NGS applications | $61.81M | $57.44M | $52.64M | $53.03M | $55.28M | $51.15M | $48.64M | $45.54M | $43.40M | $40.77M | $39.42M | $37.11M | 52.2% | +11.8% |
| DNA synthesis and protein solutions | $56.57M | $53.27M | $51.06M | $6.44M | $40.77M | $41.65M | $40.07M | $5.30M | $5.10M | $4.70M | $5.23M | $3.39M | 47.8% | +38.7% |
| Synthetic genes | – | – | – | $31.22M | $27.68M | $28.22M | $26.49M | $25.65M | $24.95M | $22.36M | $19.73M | $20.05M | – | – |
| Oligo pools | – | – | – | $5.00M | $5.42M | $4.71M | $5.09M | $4.61M | $4.17M | $3.94M | $4.19M | $3.74M | – | – |
| DNA libraries | – | – | – | $3.32M | $2.06M | $3.02M | $2.79M | $3.62M | $3.85M | $3.53M | $2.94M | $2.66M | – | – |
By region
| Revenue | Q3 26 | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Americas | $77.26M | $64.31M | $58.38M | $57.30M | $59.39M | $55.19M | $53.71M | $52.66M | $51.39M | $45.87M | $43.96M | $43.68M | 65.3% | +30.1% |
| EMEA | $33.62M | $37.35M | $38.37M | $34.55M | $30.74M | $30.64M | $28.30M | $25.50M | $23.58M | $22.26M | $21.22M | $17.21M | 28.4% | +9.4% |
| APAC | $7.50M | $9.06M | $6.95M | $7.16M | $5.93M | $6.96M | $6.70M | $6.54M | $6.49M | $7.17M | $6.32M | $6.06M | 6.3% | +26.4% |
From the segment and revenue-disaggregation notes of Twist Bioscience's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.